​

Myriad Genetics Ownership | Who Owns Myriad Genetics?


OverviewForecastRevenueFinancialsChartTranscripts

Myriad Genetics Ownership Summary


Myriad Genetics is owned by 96.81% institutional investors, 3.98% insiders. Blackrock is the largest institutional shareholder, holding 18.54% of MYGN shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.09% of its assets in Myriad Genetics shares.

MYGN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockMyriad Genetics96.81%3.98%-0.78%
SectorHealthcare Stocks 247.07%12.15%-159.22%
IndustryDiagnostics & Research Stocks87.40%9.69%2.92%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock15.15M18.54%$370.59M
Blackrock funding, inc. /de15.92M16.80%$68.63M
Vanguard group8.23M8.84%$50.59M
Millennium management6.62M7.07%$37.80M
Vestal point capital, lp5.74M6.12%$32.75M
Glenview capital management5.41M5.80%$24.35M
State street4.80M5.06%$20.68M
D. e. shaw4.58M4.89%$26.16M
Vanguard capital management4.00M4.22%$17.26M
Acadian asset management3.46M3.65%$14.89M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Amh equity400.00K3.60%$2.89M
Camber capital management lp2.00M1.00%$10.62M
Vestal point capital, lp5.74M0.77%$32.75M
Glenview capital management5.41M0.61%$24.35M
Anson funds management lp504.38K0.33%$3.65M
Alpha wealth funds20.00K0.28%$84.60K
Verdad advisers, lp37.50K0.21%$214.13K
Dynamic technology lab private54.05K0.06%$233.00K
Isam funds (uk)31.65K0.05%$228.85K
Quantessence capital19.11K0.04%$138.19K

Top Buyers

HolderShares% AssetsChange
Blackrock funding, inc. /de15.92M0.00%5.03M
Vestal point capital, lp5.74M0.77%4.09M
Citadel advisors1.53M0.00%1.08M
Mackenzie financial2.50M0.01%963.65K
Aqr capital management2.77M0.01%854.39K

Top Sellers

HolderShares% AssetsChange
Orbimed advisors---125.00M
Wellington management group llp---4.59M
Earnest partners---3.98M
Artisan partners limited partnership---2.28M
Loomis sayles & co l p---2.19M

New Positions

HolderShares% AssetsChangeValue
Zacks investment management81.39K0.00%81.39K$464.75K
Employees retirement system of texas56.33K0.00%56.33K$243.00K
Verdad advisers, lp37.50K0.21%37.50K$214.13K
Isam funds (uk)31.65K0.05%31.65K$228.85K
Vise27.07K0.00%27.07K$116.68K

Sold Out

HolderChange
Cnb bank-1.00
Global financial private client-3.00
Mendota financial group-3.00
Jfs wealth advisors-3.00
Mather group, llc.-3.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2026199-2.45%90,708,053-57.39%960.19%11810.28%58-15.94%
Mar 31, 2026198-10.00%212,223,284130.12%2272.32%104-10.34%66-10.81%
Dec 31, 202563-71.49%13,263,036-85.02%140.16%30-74.36%21-70.42%
Sep 30, 202579-62.74%17,328,183-77.55%180.27%39-69.29%25-52.83%
Jun 30, 2025218-5.63%90,330,011-3.80%970.92%1308.33%52-32.47%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF5.70M6.09%-224.78K
Vanguard Explorer Inv3.10M3.40%-190.91K
State Street® SPDR® S&P® Biotech ETF3.04M3.18%79.57K
Vanguard Morn Total Stk Mkt Idx Investor2.88M3.05%104.80K
Vanguard Total Stock Mkt Idx Inv2.88M3.05%104.80K
Vanguard MStar Total Stk Mkt Idx Invest2.88M3.01%-
Vanguard US Total Market Shares ETF2.70M2.96%2.75K
iShares Russell 2000 ETF2.30M2.40%-
Artisan Non-U.S. Small-Mid Growth Comp1.56M1.70%-281.57K
Artisan International Small-Mid Investor1.56M1.70%-281.57K

Recent Insider Transactions


DateNameRoleActivityValue
Jun 08, 2026Kumar Rashmi-Sell$66.84K
May 14, 2026Bisaro Paul-Buy$27.64K
Mar 09, 2026Raha Samraat S. President and CEOBuy$199.84K
Feb 27, 2026Phanstiel S. Louise-Buy$223.73K
Feb 26, 2026Phanstiel S. Louise-Buy$242.10K

Insider Transactions Trends


DateBuySell
2026 Q4--
2026 Q3--
2026 Q211
2026 Q14-
2025 Q4--

MYGN Ownership FAQ


Who Owns Myriad Genetics?

Myriad Genetics shareholders are primarily institutional investors at 96.81%, followed by 3.98% insiders and -0.79% retail investors. The average institutional ownership in Myriad Genetics's industry, Diagnostics & Research Stocks, is 87.40%, which Myriad Genetics exceeds.

Who owns the most shares of Myriad Genetics?

Myriad Genetics’s largest shareholders are Blackrock (15.15M shares, 18.54%), Blackrock funding, inc. /de (15.92M shares, 16.80%), and Vanguard group (8.23M shares, 8.84%). Together, they hold 44.17% of Myriad Genetics’s total shares outstanding.

Does Blackrock own Myriad Genetics?

Yes, BlackRock owns 18.54% of Myriad Genetics, totaling 15.15M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 370.59M$. In the last quarter, BlackRock increased its holdings by 271.49K shares, a 1.82% change.

Who is Myriad Genetics’s biggest shareholder by percentage of total assets invested?

Amh equity is Myriad Genetics’s biggest shareholder by percentage of total assets invested, with 3.60% of its assets in 400K Myriad Genetics shares, valued at 2.89M$.

Who is the top mutual fund holder of Myriad Genetics shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Myriad Genetics shares, with 6.09% of its total shares outstanding invested in 5.7M Myriad Genetics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools